 | • レポートコード：QY2207C3483 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、73ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のダラツムマブ注射の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にダラツムマブ注射の世界市場のxxx％を占める「100mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のダラツムマブ注射の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのダラツムマブ注射市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのダラツムマブ注射市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ダラツムマブ注射のグローバル主要メーカーには、Johnson & Johnson、Xi'an Janssen Pharmaceutical、Shanghai Henlius Biotechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ダラツムマブ注射市場は、種類と用途によって区分されます。世界のダラツムマブ注射市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 100mg、400mg 【用途別セグメント】 病院、クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ダラツムマブ注射製品概要 - 種類別市場（100mg、400mg） - 用途別市場（病院、クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のダラツムマブ注射販売量予測2017-2028 - 世界のダラツムマブ注射売上予測2017-2028 - ダラツムマブ注射の地域別販売量 - ダラツムマブ注射の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ダラツムマブ注射販売量 - 主要メーカー別ダラツムマブ注射売上 - 主要メーカー別ダラツムマブ注射価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（100mg、400mg） - ダラツムマブ注射の種類別販売量 - ダラツムマブ注射の種類別売上 - ダラツムマブ注射の種類別価格 ・用途別市場規模（病院、クリニック、その他） - ダラツムマブ注射の用途別販売量 - ダラツムマブ注射の用途別売上 - ダラツムマブ注射の用途別価格 ・北米市場 - 北米のダラツムマブ注射市場規模（種類別、用途別） - 主要国別のダラツムマブ注射市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのダラツムマブ注射市場規模（種類別、用途別） - 主要国別のダラツムマブ注射市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のダラツムマブ注射市場規模（種類別、用途別） - 主要国別のダラツムマブ注射市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のダラツムマブ注射市場規模（種類別、用途別） - 主要国別のダラツムマブ注射市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのダラツムマブ注射市場規模（種類別、用途別） - 主要国別のダラツムマブ注射市場規模（トルコ、サウジアラビア） ・企業情報 Johnson & Johnson、Xi'an Janssen Pharmaceutical、Shanghai Henlius Biotech ・産業チェーン及び販売チャネル分析 - ダラツムマブ注射の産業チェーン分析 - ダラツムマブ注射の原材料 - ダラツムマブ注射の生産プロセス - ダラツムマブ注射の販売及びマーケティング - ダラツムマブ注射の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ダラツムマブ注射の産業動向 - ダラツムマブ注射のマーケットドライバー - ダラツムマブ注射の課題 - ダラツムマブ注射の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Daratumumab Injection Market
The global Daratumumab Injection market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, 100 mg accounting for % of the Daratumumab Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Daratumumab Injection market size is valued at US$ million in 2021, while the North America and Europe Daratumumab Injection are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Daratumumab Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Daratumumab Injection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Daratumumab Injection market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Daratumumab Injection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Daratumumab Injection market.
Global Daratumumab Injection Scope and Market Size
Daratumumab Injection market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Daratumumab Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100 mg
400 mg
Segment by Application
Hospital
Clinic
Others
By Company
Johnson & Johnson
Xi’an Janssen Pharmaceutical
Shanghai Henlius Biotech
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Daratumumab Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100 mg
1.2.3 400 mg
1.3 Market by Application
1.3.1 Global Daratumumab Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Daratumumab Injection Market Perspective (2017-2028)
2.2 Daratumumab Injection Growth Trends by Region
2.2.1 Daratumumab Injection Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Daratumumab Injection Historic Market Size by Region (2017-2022)
2.2.3 Daratumumab Injection Forecasted Market Size by Region (2023-2028)
2.3 Daratumumab Injection Market Dynamics
2.3.1 Daratumumab Injection Industry Trends
2.3.2 Daratumumab Injection Market Drivers
2.3.3 Daratumumab Injection Market Challenges
2.3.4 Daratumumab Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Daratumumab Injection Players by Revenue
3.1.1 Global Top Daratumumab Injection Players by Revenue (2017-2022)
3.1.2 Global Daratumumab Injection Revenue Market Share by Players (2017-2022)
3.2 Global Daratumumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Daratumumab Injection Revenue
3.4 Global Daratumumab Injection Market Concentration Ratio
3.4.1 Global Daratumumab Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Daratumumab Injection Revenue in 2021
3.5 Daratumumab Injection Key Players Head office and Area Served
3.6 Key Players Daratumumab Injection Product Solution and Service
3.7 Date of Enter into Daratumumab Injection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Daratumumab Injection Breakdown Data by Type
4.1 Global Daratumumab Injection Historic Market Size by Type (2017-2022)
4.2 Global Daratumumab Injection Forecasted Market Size by Type (2023-2028)
5 Daratumumab Injection Breakdown Data by Application
5.1 Global Daratumumab Injection Historic Market Size by Application (2017-2022)
5.2 Global Daratumumab Injection Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Daratumumab Injection Market Size (2017-2028)
6.2 North America Daratumumab Injection Market Size by Type
6.2.1 North America Daratumumab Injection Market Size by Type (2017-2022)
6.2.2 North America Daratumumab Injection Market Size by Type (2023-2028)
6.2.3 North America Daratumumab Injection Market Share by Type (2017-2028)
6.3 North America Daratumumab Injection Market Size by Application
6.3.1 North America Daratumumab Injection Market Size by Application (2017-2022)
6.3.2 North America Daratumumab Injection Market Size by Application (2023-2028)
6.3.3 North America Daratumumab Injection Market Share by Application (2017-2028)
6.4 North America Daratumumab Injection Market Size by Country
6.4.1 North America Daratumumab Injection Market Size by Country (2017-2022)
6.4.2 North America Daratumumab Injection Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Daratumumab Injection Market Size (2017-2028)
7.2 Europe Daratumumab Injection Market Size by Type
7.2.1 Europe Daratumumab Injection Market Size by Type (2017-2022)
7.2.2 Europe Daratumumab Injection Market Size by Type (2023-2028)
7.2.3 Europe Daratumumab Injection Market Share by Type (2017-2028)
7.3 Europe Daratumumab Injection Market Size by Application
7.3.1 Europe Daratumumab Injection Market Size by Application (2017-2022)
7.3.2 Europe Daratumumab Injection Market Size by Application (2023-2028)
7.3.3 Europe Daratumumab Injection Market Share by Application (2017-2028)
7.4 Europe Daratumumab Injection Market Size by Country
7.4.1 Europe Daratumumab Injection Market Size by Country (2017-2022)
7.4.2 Europe Daratumumab Injection Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Daratumumab Injection Market Size (2017-2028)
8.2 Asia-Pacific Daratumumab Injection Market Size by Type
8.2.1 Asia-Pacific Daratumumab Injection Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Daratumumab Injection Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Daratumumab Injection Market Share by Type (2017-2028)
8.3 Asia-Pacific Daratumumab Injection Market Size by Application
8.3.1 Asia-Pacific Daratumumab Injection Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Daratumumab Injection Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Daratumumab Injection Market Share by Application (2017-2028)
8.4 Asia-Pacific Daratumumab Injection Market Size by Region
8.4.1 Asia-Pacific Daratumumab Injection Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Daratumumab Injection Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Daratumumab Injection Market Size (2017-2028)
9.2 Latin America Daratumumab Injection Market Size by Type
9.2.1 Latin America Daratumumab Injection Market Size by Type (2017-2022)
9.2.2 Latin America Daratumumab Injection Market Size by Type (2023-2028)
9.2.3 Latin America Daratumumab Injection Market Share by Type (2017-2028)
9.3 Latin America Daratumumab Injection Market Size by Application
9.3.1 Latin America Daratumumab Injection Market Size by Application (2017-2022)
9.3.2 Latin America Daratumumab Injection Market Size by Application (2023-2028)
9.3.3 Latin America Daratumumab Injection Market Share by Application (2017-2028)
9.4 Latin America Daratumumab Injection Market Size by Country
9.4.1 Latin America Daratumumab Injection Market Size by Country (2017-2022)
9.4.2 Latin America Daratumumab Injection Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Daratumumab Injection Market Size (2017-2028)
10.2 Middle East & Africa Daratumumab Injection Market Size by Type
10.2.1 Middle East & Africa Daratumumab Injection Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Daratumumab Injection Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Daratumumab Injection Market Share by Type (2017-2028)
10.3 Middle East & Africa Daratumumab Injection Market Size by Application
10.3.1 Middle East & Africa Daratumumab Injection Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Daratumumab Injection Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Daratumumab Injection Market Share by Application (2017-2028)
10.4 Middle East & Africa Daratumumab Injection Market Size by Country
10.4.1 Middle East & Africa Daratumumab Injection Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Daratumumab Injection Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Daratumumab Injection Introduction
11.1.4 Johnson & Johnson Revenue in Daratumumab Injection Business (2017-2022)
11.1.5 Johnson & Johnson Recent Developments
11.2 Xi’an Janssen Pharmaceutical
11.2.1 Xi’an Janssen Pharmaceutical Company Details
11.2.2 Xi’an Janssen Pharmaceutical Business Overview
11.2.3 Xi’an Janssen Pharmaceutical Daratumumab Injection Introduction
11.2.4 Xi’an Janssen Pharmaceutical Revenue in Daratumumab Injection Business (2017-2022)
11.2.5 Xi’an Janssen Pharmaceutical Recent Developments
11.3 Shanghai Henlius Biotech
11.3.1 Shanghai Henlius Biotech Company Details
11.3.2 Shanghai Henlius Biotech Business Overview
11.3.3 Shanghai Henlius Biotech Daratumumab Injection Introduction
11.3.4 Shanghai Henlius Biotech Revenue in Daratumumab Injection Business (2017-2022)
11.3.5 Shanghai Henlius Biotech Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer